Brief: Armata Pharmaceuticals Announces $45 Million Investment To Support Advancement Of The Company's Bacteriophage Development
09/02/2022 21:52
Feb 9 (Reuters) - Armata Pharmaceuticals Inc ARMP.A :
* ARMATA PHARMACEUTICALS ANNOUNCES $45 MILLION INVESTMENT TO
SUPPORT ADVANCEMENT OF THE COMPANY'S BACTERIOPHAGE DEVELOPMENT
* ARMATA PHARMACEUTICALS - ENTERED INTO SECURITIES PURCHASE
AGREEMENT TO SELL ARMATA COMMON STOCK AND WARRANTS TO INNOVIVA
STRATEGIC OPPORTUNITIES LLC
Source text for Eikon: ID:nPnCv4yTa
Further company coverage: ARMP.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Armata Pharmaceuticals
See all newsBrief: Armata Pharmaceuticals Announces First Quarter 2026 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Delays Announcement Of Fourth Quarter And Full-Year 2025 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Receives FDA Qualified Infectious Disease Product Designation
Armata Pharma jumps on US FDA nod for late-stage infection trial
Brief: Armata Pharmaceuticals Commissions cGMP Manufacturing Facility In Los Angeles